Skip to content
MedsAcross

Medicine

Enalapril and Hydrochlorothiazide 10 mg/25 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Enalapril and Hydrochlorothiazide 10 mg/25 mg tablet is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F). Protect from moisture.

Key facts

Active ingredient (INN)
Enalapril and Hydrochlorothiazide
Brand
Sold under the generic name
Strength
10 mg/25 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 1000 tablets and 1 more
Manufacturers
Dr. Reddy's LaboratoriesIndiaSun Pharmaceutical IndustriesIndia
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
18 September 2001
Identifiers
RxCUI 858824, 858828DailyMed set ID 7cb92cf2-46f2-4379-937c-168d230e43a4, ed4a55a6-cd6a-c74a-cb93-4b45641691a0NDC 51672-4046, 55111-134Application ANDA075788, ANDA075909

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle55111-134-01Dr. Reddy's LaboratoriesIndia15 October 2001
1000 tablet in 1 bottle55111-134-10Dr. Reddy's LaboratoriesIndia15 October 2001
100 tablet in 1 bottle51672-4046-1Sun Pharmaceutical IndustriesIndia18 September 2001
1000 tablet in 1 bottle51672-4046-3Sun Pharmaceutical IndustriesIndia18 September 2001

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 October 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Enalapril and Hydrochlorothiazide 10 mg/25 mg tablet.

Compare 1

Other strengths and forms of Enalapril and Hydrochlorothiazide

Clinical summary

Enalapril and Hydrochlorothiazide is a fixed-dose combination of an angiotensin converting enzyme inhibitor and a thiazide diuretic indicated for the treatment of hypertension. It is available as tablets for oral use. MedsAcross supplies Enalapril and Hydrochlorothiazide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Enalapril and Hydrochlorothiazide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Enalapril and Hydrochlorothiazide 10 mg/25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.